Abstract:The endoplasmic reticulum (ER) is a cellular organelle that is physiologically responsible for protein folding, calcium homeostasis, and lipid biosynthesis. Pathological stimuli such as oxidative stress, ischemia, disruptions in calcium homeostasis, and increased production of normal and/or folding-defective proteins all contribute to the accumulation of misfolded proteins in the ER, causing ER stress. The adaptive response to ER stress is the activation of unfolded protein response (UPR), which affect a wide variety of cellular functions to maintain ER homeostasis or lead to apoptosis. Three different ER transmembrane sensors, including PKR-like ER kinase (PERK), activating transcription factor 6 (ATF6), and inositol-requiring enzyme-1 (IRE1), are responsible for initiating UPR. The UPR involves a variety of signal transduction pathways that reduce unfolded protein accumulation by boosting ER-resident chaperones, limiting protein translation, and accelerating unfolded protein degradation. ER is now acknowledged as a critical organelle in sensing dangers and determining cell life and death. On the other hand, UPR plays a critical role in the development and progression of several diseases such as cardiovascular diseases (CVD), metabolic disorders, chronic kidney diseases, neurological disorders, and cancer. Here, we critically analyze the most current knowledge of the master regulatory roles of ER stress particularly the PERK pathway as a conditional danger receptor, an organelle crosstalk regulator, and a regulator of protein translation. We highlighted that PERK is not only ER stress regulator by sensing UPR and ER stress but also a frontier sensor and direct senses for gut microbiota-generated metabolites. Our work also further highlighted the function of PERK as a central hub that leads to metabolic reprogramming and epigenetic modification which further enhanced inflammatory response and promoted trained immunity. Moreover, we highlighted the contribution of ER stress and PERK in the pathogenesis of several diseases such as cancer, CVD, kidney diseases, and neurodegenerative disorders. Finally, we discuss the therapeutic target of ER stress and PERK for cancer treatment and the potential novel therapeutic targets for CVD, metabolic disorders, and neurodegenerative disorders. Inhibition of ER stress, by the development of small molecules that target the PERK and UPR, represents a promising therapeutic strategy.

Developmentally regulated PERK activity renders dendritic cells insensitive to subtilase cytotoxin-induced integrated stress response

Proteostasis in Dendritic Cells is Controlled by the PERK Signaling Axis Independently of ATF4

Transcription factor E2F1 suppresses dendritic cell maturation.

Transcription factor E2F1 suppresses dendritic cell maturation. (167.3)

eIF2α phosphorylation as a biomarker of immunogenic cell death.

Control of PERK Eif2α Kinase Activity by the Endoplasmic Reticulum Stress-Induced Molecular Chaperone P58 IPK

The eIF2α kinase PERK limits the expression of hippocampal metabotropic glutamate receptor-dependent long-term depression.

Perk Is Essential for Translational Regulation and Cell Survival during the Unfolded Protein Response

The eIF2 kinase PERK and the integrated stress response facilitate activation of ATF6 during endoplasmic reticulum stress

Antagonistic Crosstalk Fine-Tunes Sensitivities of IRE1 and PERK Signaling During Unfolded Protein Response

Protein Phosphatase 1 Subunit Ppp1r15a/GADD34 Regulates Cytokine Production in Polyinosinic:Polycytidylic Acid-Stimulated Dendritic Cells

Decreased Store Operated Ca2+ Entry in Dendritic Cells Isolated from Mice Expressing PKB/SGK-Resistant GSK3

The unfolded protein response: controlling cell fate decisions under ER stress and beyond

The Unfolded Protein Response Mediator PERK Governs Myeloid Cell-Driven Immunosuppression in Tumors Through Inhibition of STING Signaling.

Ctenopharyngodon Idella PERK (EIF2AK3) Decreases Cell Viability by Phosphorylating Eif2α under ER Stress.

Brain-specific Disruption of the Eif2α Kinase PERK Decreases ATF4 Expression and Impairs Behavioral Flexibility.

The integrated stress response/eIF2a pathway controls cytokine production in tissue-resident memory CD4 T cells

IRE1 signaling increases PERK expression during chronic ER stress

Congress of multiple dimers is needed for cross-phosphorylation of IRE1α and its RNase activity

Endoplasmic reticulum stress and its regulator XBP-1 contributes to dendritic cell maturation and activation induced by high mobility group box-1 protein

Protein-rich foods, sea foods, and gut microbiota amplify immune responses in chronic diseases and cancers - Targeting PERK as a novel therapeutic strategy for chronic inflammatory diseases, neurodegenerative disorders, and cancer